Literature DB >> 19291825

Prognostic factors for 5-year survival after local excision of rectal cancer.

Dong-Bing Zhao1, Yong-Kai Wu, Yong-Fu Shao, Cheng-Feng Wang, Jian-Qiang Cai.   

Abstract

AIM: To evaluate the prognostic factors for 5-year survival after local excision of rectal cancer, and to examine the therapeutic efficacy and surgical indications for this procedure.
METHODS: Clinical data, obtained from 106 local rectal cancer excisions performed between January 1980 and December 2005, were retrospectively analyzed. Survival analysis was performed using the Kaplan-Meier method, statistical comparisons were performed using the log-rank test, and multivariate analysis was performed using the Cox proportional hazards model.
RESULTS: Transanal, transsacral, and transvaginal excisions were performed in 92, 12, and 2 cases, respectively. The rate of complication, local recurrence, and 5-year survival was 6.6%, 17.0%, and 86.7%, respectively. Univariate analysis showed that T stage, vascular invasion, and local recurrence were related to the prognosis of the cases (P < 0.05). Multivariate analysis showed that T stage [P = 0.011, 95% confidence interval (CI) = 1.194-3.878] and local recurrence (P = 0.022, 95% CI = 1.194-10.160) were the major prognostic factors for 5-year survival of cases after local excision of rectal cancer.
CONCLUSION: Local rectal cancer excision is associated with few complications, and suitable for stages Tis and T1 rectal cancer. Prevention of local recurrence, active postoperative follow-up, and administration of salvage therapy are the effective methods to increase the efficacy of local excision of rectal cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19291825      PMCID: PMC2658846          DOI: 10.3748/wjg.15.1242

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Transanal excision for low rectal cancers is curative in early-stage disease with favorable histology.

Authors:  S Blair; J D Ellenhorn
Journal:  Am Surg       Date:  2000-09       Impact factor: 0.688

Review 2.  Local therapy for rectal cancer.

Authors:  B C Visser; M G Varma; M L Welton
Journal:  Surg Oncol       Date:  2001 Jul-Aug       Impact factor: 3.279

Review 3.  Role of local excision in the treatment of rectal cancer.

Authors:  D A Rothenberger; J Garcia-Aguilar
Journal:  Semin Surg Oncol       Date:  2000-12

4.  Local excision of T2 and T3 rectal cancers after downstaging chemoradiation.

Authors:  C J Kim; T J Yeatman; D Coppola; A Trotti; B Williams; J S Barthel; W Dinwoodie; R C Karl; J Marcet
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

5.  Local excision of rectal carcinoma.

Authors:  M I Chorost; N J Petrelli; M McKenna; W G Kraybill; M A Rodriguez-Bigas
Journal:  Am Surg       Date:  2001-08       Impact factor: 0.688

6.  Should locally excised T1 rectal cancer receive adjuvant chemoradiation?

Authors:  J P Lamont; T M McCarty; R D Digan; R Jacobson; P Tulanon; W E Lichliter
Journal:  Am J Surg       Date:  2000-12       Impact factor: 2.565

7.  Local excision of rectal cancer: what is the evidence?

Authors:  S Sengupta; J J Tjandra
Journal:  Dis Colon Rectum       Date:  2001-09       Impact factor: 4.585

Review 8.  Preoperative staging of rectal cancer.

Authors:  H Kwok; I P Bissett; G L Hill
Journal:  Int J Colorectal Dis       Date:  2000-02       Impact factor: 2.571

9.  Long-term survival after local excision for T1 carcinoma of the rectum.

Authors:  Riccardo Nascimbeni; Santhat Nivatvongs; Dirk R Larson; Lawrence J Burgart
Journal:  Dis Colon Rectum       Date:  2004-11       Impact factor: 4.585

10.  Salvage radical surgery after failed local excision for early rectal cancer.

Authors:  Charles M Friel; John W Cromwell; Claudio Marra; Robert D Madoff; David A Rothenberger; Julio Garcia-Aguílar
Journal:  Dis Colon Rectum       Date:  2002-07       Impact factor: 4.585

View more
  5 in total

1.  Does a learning curve exist in endorectal two-dimensional ultrasound accuracy?

Authors:  O J Morris; B Draganic; S Smith
Journal:  Tech Coloproctol       Date:  2011-07-09       Impact factor: 3.781

2.  Is limited surgery justified in the treatment of T1 colorectal cancer?

Authors:  Pamela Kogler; Reinhold Kafka-Ritsch; Dietmar Öfner; Michael Sieb; Florian Augustin; Johann Pratschke; Matthias Zitt
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

3.  Feasibility of robot-assisted surgery in elderly patients with rectal cancer.

Authors:  Wei-Chih Su; Ching-Wen Huang; Cheng-Jen Ma; Po-Jung Chen; Hsiang-Lin Tsai; Tsung-Kun Chang; Yen-Cheng Chen; Ching-Chun Li; Yung-Sung Yeh; Jaw-Yuan Wang
Journal:  J Minim Access Surg       Date:  2021 Apr-Jun       Impact factor: 1.407

4.  Anorectal gastrointestinal stromal tumor: a case report and literature review.

Authors:  Sanjeev Singhal; Anu Singhal; Rahul Tugnait; Vineet Varghese; Bishwanath Tiwari; Pankaj K Arora; Pawan Malik; Mriganka Deuri Bharali; Ankur Subhash Dhuria; Pushkar Chauhan; Chandrakant Singh; Amit Ballani; Vishnu Panwar
Journal:  Case Rep Gastrointest Med       Date:  2013-03-25

5.  A case of local recurrence of T1 rectal cancer 10 years after transanal excision.

Authors:  Hideharu Tanaka; Koji Komori; Takashi Kinoshita; Taihei Oshiro; Seiji Ito; Tetsuya Abe; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Norihisa Uemura; Seiji Natsume; Eiji Higaki; Akira Ouchi; Masayuki Tsutsuyama; Takahiro Hosoi; Itaru Shigeyoshi; Byonggu An; Tomoyuki Akazawa; Daisuke Hayashi; Tairin Uchino; Aina Kunitomo; Yasuhiro Shimizu
Journal:  Nagoya J Med Sci       Date:  2018-02       Impact factor: 1.131

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.